Viewing Study NCT04787523



Ignite Creation Date: 2024-05-06 @ 3:52 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04787523
Status: COMPLETED
Last Update Posted: 2023-11-07
First Post: 2021-02-27

Brief Title: Rectrospect - a Retrospective Study of Treatment Response
Sponsor: Sahlgrenska University Hospital Sweden
Organization: Sahlgrenska University Hospital Sweden

Study Overview

Official Title: Rectrospect - a Study on the Immun Cell Infiltrate in a Retrospective Rectal Cancer Cohort
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Rectrospect
Brief Summary: Biopisies from patients diagnosed with rectal cancer between 2007-2019 will be cut into 4-6 micrometer thin sections for morphology and immunostaining Every section will be numbered with a code that is connected to the patients personal identification number and the code list will be kept separately from the biopsies in a password protected file on the Sahlgrenska University Hospital server

Patient data and outcome regarding response to treatment will be collected from patient charts and the Swedish ColoRectal Cancer Registry but all data will be numbered with the same code number and all results will be kept away from the code list In order to achieve the stated aims that is to study how the molecular and cellular characteristics of the tumour and its surrounding microenvironment as well as the interaction of tumour cells and immune cells affect treatment response several molecular and cellular techniques and assays may be applied
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None